It should be noted that most BPC-157 research has been conducted in animal models
Other joints that are frequently affected include the mid-foot, ankle, knee, wrists and finger joints
Populations who should not use BPC-157: Pregnant or breastfeeding individuals (no safety data), anyone with a history of cancer (theoretical concern given pro-angiogenic mechanisms), individuals taking anticoagulants (some animal data suggest effects on platelet aggregation pathways), and anyone without access to sterile technique for injection preparation
Even in Russia, they don't really look kindly to this research
This peptide is frequently investigated for its involvement in IGF-1 receptor activation, protein-synthesis signalling, cellular proliferation pathways, and metabolic-response research